BAX Stock Overview
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 2/6 |
Baxter International Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$38.20 |
52 Week High | US$44.35 |
52 Week Low | US$30.05 |
Beta | 0.62 |
1 Month Change | -2.92% |
3 Month Change | 10.25% |
1 Year Change | 3.72% |
3 Year Change | -47.47% |
5 Year Change | -47.43% |
Change since IPO | -35.49% |
Recent News & Updates
Recent updates
Shareholder Returns
BAX | AT Medical Equipment | AT Market | |
---|---|---|---|
7D | -0.4% | -0.8% | 0.9% |
1Y | 3.7% | 14.2% | 6.9% |
Return vs Industry: BAX underperformed the Austrian Medical Equipment industry which returned 12.8% over the past year.
Return vs Market: BAX underperformed the Austrian Market which returned 7.4% over the past year.
Price Volatility
BAX volatility | |
---|---|
BAX Average Weekly Movement | 3.4% |
Medical Equipment Industry Average Movement | 5.5% |
Market Average Movement | 3.3% |
10% most volatile stocks in AT Market | 5.0% |
10% least volatile stocks in AT Market | 1.6% |
Stable Share Price: BAX has not had significant price volatility in the past 3 months.
Volatility Over Time: BAX's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1931 | 60,000 | Joe Almeida | https://www.baxter.com |
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
Baxter International Inc. Fundamentals Summary
BAX fundamental statistics | |
---|---|
Market cap | €19.65b |
Earnings (TTM) | -€70.17m |
Revenue (TTM) | €13.68b |
1.4x
P/S Ratio-278.4x
P/E RatioIs BAX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BAX income statement (TTM) | |
---|---|
Revenue | US$14.81b |
Cost of Revenue | US$9.15b |
Gross Profit | US$5.66b |
Other Expenses | US$5.74b |
Earnings | -US$76.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.15 |
Gross Margin | 38.22% |
Net Profit Margin | -0.51% |
Debt/Equity Ratio | 162.1% |
How did BAX perform over the long term?
See historical performance and comparison